NEW DISTRIBUTION AGREEMENT WITH MONTEBELLO DIAGNOSTICS

NEW DISTRIBUTION AGREEMENT WITH MONTEBELLO DIAGNOSTICS

Trieste, January 20th 2025 - Ulisse Biomed, an Italian healthcare biotech company operating in the diagnostics, theranostics, and therapeutics sectors, announces that it has signed a new distribution agreement with Montebello Diagnostics.

Montebello Diagnostics is a Norwegian company, a leader in the distribution and commercialization of diagnostic solutions for hospital laboratories, research laboratories, and food laboratories, with many years of experience and a consolidated business in the field of HPV solutions.

The agreement provides for the distribution of Ulisse Biomed's proprietary solutions for HPV screening and genotyping, as well as the Hyris System™, a proprietary hardware and software platform for genetic analysis.

The agreement includes the exclusive distribution of Ulisse Biomed solutions in the Norwegian market and non-exclusive distribution in the Swedish, Danish, and Finnish markets.

“We are proud to initiate this commercial relationship with a key player in the Scandinavian markets,” says Gabriele Salaris, Head of Marketing & Sales at Ulisse Biomed. “Montebello Diagnostics has deep experience and knowledge of HPV solutions, with an already established business. A partnership of this level will help us develop the Scandinavian market, with a primary focus on Norway,” concludes Salaris.